Genetic pathways, prevention, and treatment of sporadic colorectal cancer

Rasika Mundade, Thomas F. Imperiale, Lakshmi Prabhu, Patrick J. Loehrer, Tao Lu

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Epithelial cancer of the colon and rectum, also known as colorectal cancer (CRC), results from a progressive accumulation of genetic and epigenetic alterations that lead to uncontrolled growth of colonocytes, the cells lining the colon and rectum. CRC is the second leading cause of cancer-related deaths and the third most common cancer in men and in women in the U.S. Of all the patients diagnosed with CRC every year, it is estimated that the vast majority of CRCs are non-hereditary "sporadic cancers" with no apparent evidence of an inherited component. Sporadic CRC results from the cumulative effects of multiple genetic and epigenetic alterations caused by somatic mutations, which may themselves be the indirect result of several environmental factors. This review examines our current understanding of the major genetic alterations leading to colon cancer, options for prevention and early detection of CRC, and the currently available treatment approaches that may target these different genetic alterations.

Original languageEnglish (US)
Pages (from-to)400-406
Number of pages7
JournalOncoscience
Volume1
Issue number6
DOIs
StatePublished - 2014

Fingerprint

Colorectal Neoplasms
Epigenomics
Colonic Neoplasms
Therapeutics
Neoplasms
Rectal Neoplasms
Early Detection of Cancer
Rectum
Colon
Mutation
Growth

Keywords

  • Colon cancer
  • Genetic pathway
  • Sporadic

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Genetic pathways, prevention, and treatment of sporadic colorectal cancer. / Mundade, Rasika; Imperiale, Thomas F.; Prabhu, Lakshmi; Loehrer, Patrick J.; Lu, Tao.

In: Oncoscience, Vol. 1, No. 6, 2014, p. 400-406.

Research output: Contribution to journalArticle

@article{fdc22f7d35724437aefda969784400c6,
title = "Genetic pathways, prevention, and treatment of sporadic colorectal cancer",
abstract = "Epithelial cancer of the colon and rectum, also known as colorectal cancer (CRC), results from a progressive accumulation of genetic and epigenetic alterations that lead to uncontrolled growth of colonocytes, the cells lining the colon and rectum. CRC is the second leading cause of cancer-related deaths and the third most common cancer in men and in women in the U.S. Of all the patients diagnosed with CRC every year, it is estimated that the vast majority of CRCs are non-hereditary {"}sporadic cancers{"} with no apparent evidence of an inherited component. Sporadic CRC results from the cumulative effects of multiple genetic and epigenetic alterations caused by somatic mutations, which may themselves be the indirect result of several environmental factors. This review examines our current understanding of the major genetic alterations leading to colon cancer, options for prevention and early detection of CRC, and the currently available treatment approaches that may target these different genetic alterations.",
keywords = "Colon cancer, Genetic pathway, Sporadic",
author = "Rasika Mundade and Imperiale, {Thomas F.} and Lakshmi Prabhu and Loehrer, {Patrick J.} and Tao Lu",
year = "2014",
doi = "10.18632/oncoscience.59",
language = "English (US)",
volume = "1",
pages = "400--406",
journal = "Oncoscience",
issn = "2331-4737",
publisher = "Impact Journals",
number = "6",

}

TY - JOUR

T1 - Genetic pathways, prevention, and treatment of sporadic colorectal cancer

AU - Mundade, Rasika

AU - Imperiale, Thomas F.

AU - Prabhu, Lakshmi

AU - Loehrer, Patrick J.

AU - Lu, Tao

PY - 2014

Y1 - 2014

N2 - Epithelial cancer of the colon and rectum, also known as colorectal cancer (CRC), results from a progressive accumulation of genetic and epigenetic alterations that lead to uncontrolled growth of colonocytes, the cells lining the colon and rectum. CRC is the second leading cause of cancer-related deaths and the third most common cancer in men and in women in the U.S. Of all the patients diagnosed with CRC every year, it is estimated that the vast majority of CRCs are non-hereditary "sporadic cancers" with no apparent evidence of an inherited component. Sporadic CRC results from the cumulative effects of multiple genetic and epigenetic alterations caused by somatic mutations, which may themselves be the indirect result of several environmental factors. This review examines our current understanding of the major genetic alterations leading to colon cancer, options for prevention and early detection of CRC, and the currently available treatment approaches that may target these different genetic alterations.

AB - Epithelial cancer of the colon and rectum, also known as colorectal cancer (CRC), results from a progressive accumulation of genetic and epigenetic alterations that lead to uncontrolled growth of colonocytes, the cells lining the colon and rectum. CRC is the second leading cause of cancer-related deaths and the third most common cancer in men and in women in the U.S. Of all the patients diagnosed with CRC every year, it is estimated that the vast majority of CRCs are non-hereditary "sporadic cancers" with no apparent evidence of an inherited component. Sporadic CRC results from the cumulative effects of multiple genetic and epigenetic alterations caused by somatic mutations, which may themselves be the indirect result of several environmental factors. This review examines our current understanding of the major genetic alterations leading to colon cancer, options for prevention and early detection of CRC, and the currently available treatment approaches that may target these different genetic alterations.

KW - Colon cancer

KW - Genetic pathway

KW - Sporadic

UR - http://www.scopus.com/inward/record.url?scp=84922134601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922134601&partnerID=8YFLogxK

U2 - 10.18632/oncoscience.59

DO - 10.18632/oncoscience.59

M3 - Article

AN - SCOPUS:84922134601

VL - 1

SP - 400

EP - 406

JO - Oncoscience

JF - Oncoscience

SN - 2331-4737

IS - 6

ER -